Sfoglia per Autore
The relationship between arthralgia and accelerated bone loss in early breast cancer (EBC) patients with up-front or swith schedules of aromatase inhibitors (AIs): retrospective analysis of incidence and responcse to supplementary comedications.
2012 Manna, Gaia; Iannace, Alessandro; Emiliani, Alessandra; Losanno, Tania; Nigita, G.; Franzese, E.; Falcone, R.; Iodice, A.; Seminara, Patrizia; Frati, Luigi
cAn cArdio-vAsculAr toxicity And bmi evAluAtions predict outcomes in pAtients treAted with chemotherApy plus bevAcizumAb for metAstAtic colorectAl cAncer?
2013 Milano, Annalisa; D'Antonio, Chiara; Lombardini, Alberto; Durante, Valeria; Romiti, Adriana; Sarcina, Ida; Falcone, Rosa; Roberto, Michela; Marchetti, Paolo
mthfr c677t gene polymorphisms And susceptibility to cArdiovAsculAr Adverse events in metAstAtic colorectAl cAncer treAted with chemotherApy plus bevAcizumAb
2013 D’Antonio, C; Romiti, A; Lombardini, A; Durante, V; Milano, Annalisa; Mazzuca, Federica; Sarcina, I; Falcone, Rosa; Onesti, Ce; Iacono, D; Righini, R; Palombi, L; Marchetti, Paolo
Pharmacogenomics in lung cancer chemotherapy: a review of what the oncologist should know.
2014 Milano, Annalisa; Falcone, Rosa; Paris, I.; Lauro, Salvatore; Marchetti, Paolo; D'Antonio, Chiara; Righini, Riccardo; Onesti, CONCETTA ELISA; Bassanelli, Maria
Continuous, low-dose capecitabine for patients with recurrent colorectal cancer
2015 Romiti, Adriana; Onesti, Concetta Elisa; Roberto, Michela; Barucca, Viola; Tomao, Silverio; D’Antonio, Chiara; Durante, Valeria; Milano, Annalisa; Falcone, Rosa; Di Rocco, Roberta; Righini, Riccardo; Marchetti, Paolo
Association between proton-pump inhibitors (PPI) and metronomic capecitabine (MCAP) as salvage treatment for patients with advanced gastro-intestinal tumoursa. A randomized phase II study
2015 Milano, Annalisa; D'Antonio, Chiara; Roberto, Michela; Falcone, Rosa; DI PIETRO, FRANCESCA ROMANA; Durante, Valeria; Romiti, Adriana; Marchetti, P.
Recent advances for the treatment of pancreatic and biliary tract cancer after first-line treatment failure
2015 Onesti, CONCETTA ELISA; Romiti, Adriana; Roberto, Michela; Falcone, Rosa; Marchetti, Paolo
A metronomic schedule as salvage chemotherapy for upper gastrointestinal tract cancer
2015 Roberto, Michela; Romiti, Adriana; Onesti, CONCETTA ELISA; D'Antonio, Chiara; Milano, Annalisa; Falcone, Rosa; Barucca, Viola; Palombi, Lucia; Righini, Riccardo; Marchetti, Paolo
A rare case of palatin tonsillar metastasis from small cell lung cancer
2016 D'Antonio, Chiara; Lombardini, Alberto; Onesti, CONCETTA ELISA; Falcone, Rosa; Romiti, Adriana; Lombardi, Marianna; Lauro, Salvatore; Marchetti, Paolo
F295-fluorouracil degradation rate (5-FU-DR) could predict toxicity in breast cancer patients treated with capecitabine
2016 Onesti, C. E.; Botticelli, A.; Mazzuca, F.; Angelini, S.; Petremolo, A.; Falcone, R.; Roberto, M.; Occhipinti, M.; Romiti, A.; Lionetto, L.; Simmaco, M.; Marchetti, P.
5-Fluorouracil degradation rate could predict toxicity in stages II-III colorectal cancer patients undergoing adjuvant FOLFOX
2016 Onesti, CONCETTA ELISA; Botticelli, Andrea; LA TORRE, Marco; Borro, Marina; Gentile, Giovanna; Romiti, Adriana; Lionetto, Luana; Petremolo, Antonella; Occhipinti, Mario; Roberto, Michela; Falcone, Rosa; Simmaco, Maurizio; Marchetti, Paolo; Mazzuca, Federica
High-doses of proton pump inhibitors in refractory gastro-intestinal cancer: A case series and the state of art
2016 Falcone, Rosa; Roberto, Michela; D'Antonio, Chiara; Romiti, Adriana; Milano, Annalisa; Onesti, CONCETTA ELISA; Marchetti, Paolo; Fais, Stefano
Association Between Proton Pump Inhibitors and Metronomic Capecitabine as Salvage Treatment for Patients With Advanced Gastrointestinal Tumors: A Randomized Phase II Trial
2016 Marchetti, Paolo; Milano, Annalisa; D'Antonio, Chiara; Romiti, Adriana; Falcone, Rosa; Roberto, Michela; Fais, Stefano
Evolving treatments for advanced gastric cancer: appraisal of the survival trend
2016 Roberto, Michela; Romiti, Adriana; Onesti, CONCETTA ELISA; Zullo, Angelo; Falcone, Rosa; Marchetti, Paolo
The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer
2016 Romiti, Adriana; Roberto, Michela; D'Antonio, Chiara; Onesti, CONCETTA ELISA; Barucca, Viola; Milano, Annalisa; Gentile, Giovanna; Lionetto, Luana; Medda, Emanuela; Mazzuca, Federica; Botticelli, Andrea; Falcone, Rosa; Simmaco, Maurizio; Marchetti, Paolo
Exploring the Prognostic Role of Microsatellite Instability in Patients With Stage II Colorectal Cancer: A Systematic Review and Meta-Analysis
2016 Romiti, Adriana; Rulli, Eliana; Pilozzi, Emanuela; Gerardi, Chiara; Roberto, Michela; Legramandi, Lorenzo; Falcone, Rosa; Pacchetti, Ilaria; Marchetti, Paolo; Floriani, Irene
Evaluation of 5-fluorouracil degradation rate and pharmacogenetic profiling to predict toxicity following adjuvant capecitabine
2017 Roberto, Michela; Romiti, Adriana; Botticelli, Andrea; Mazzuca, Federica; Lionetto, Luana; Gentile, Giovanna; Paris, Ida; Falcone, Rosa; Bassanelli, Maria; DI PIETRO, FRANCESCA ROMANA; Onesti, CONCETTA ELISA; Anselmi, Elisabetta; Macrini, Serena; Simmaco, Maurizio; Marchetti, Paolo
Current achievements and future perspectives of metronomic chemotherapy
2017 Romiti, Adriana; Falcone, Rosa; Roberto, Michela; Marchetti, Paolo
The role of stereotactic body radiation therapy in oligometastatic colorectal cancer
2017 Roberto, Michela; Falcone, Rosa; Mazzuca, Federica; Archibugi, Livia; Castaldi, Nadia; Botticelli, Andrea; Osti, Mattia Falchetto; Marchetti, Paolo
Tackling pancreatic cancer with metronomic chemotherapy
2017 Romiti, Adriana; Falcone, Rosa; Roberto, Michela; Marchetti, Paolo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| The relationship between arthralgia and accelerated bone loss in early breast cancer (EBC) patients with up-front or swith schedules of aromatase inhibitors (AIs): retrospective analysis of incidence and responcse to supplementary comedications. | 2012 | Manna, Gaia; Iannace, Alessandro; Emiliani, Alessandra; Losanno, Tania; Nigita, G.; Franzese, E.; Falcone, R.; Iodice, A.; Seminara, Patrizia; Frati, Luigi | |
| cAn cArdio-vAsculAr toxicity And bmi evAluAtions predict outcomes in pAtients treAted with chemotherApy plus bevAcizumAb for metAstAtic colorectAl cAncer? | 2013 | Milano, Annalisa; D'Antonio, Chiara; Lombardini, Alberto; Durante, Valeria; Romiti, Adriana; Sarcina, Ida; Falcone, Rosa; Roberto, Michela; Marchetti, Paolo | |
| mthfr c677t gene polymorphisms And susceptibility to cArdiovAsculAr Adverse events in metAstAtic colorectAl cAncer treAted with chemotherApy plus bevAcizumAb | 2013 | D’Antonio, C; Romiti, A; Lombardini, A; Durante, V; Milano, Annalisa; Mazzuca, Federica; Sarcina, I; Falcone, Rosa; Onesti, Ce; Iacono, D; Righini, R; Palombi, L; Marchetti, Paolo | |
| Pharmacogenomics in lung cancer chemotherapy: a review of what the oncologist should know. | 2014 | Milano, Annalisa; Falcone, Rosa; Paris, I.; Lauro, Salvatore; Marchetti, Paolo; D'Antonio, Chiara; Righini, Riccardo; Onesti, CONCETTA ELISA; Bassanelli, Maria | |
| Continuous, low-dose capecitabine for patients with recurrent colorectal cancer | 2015 | Romiti, Adriana; Onesti, Concetta Elisa; Roberto, Michela; Barucca, Viola; Tomao, Silverio; D’Antonio, Chiara; Durante, Valeria; Milano, Annalisa; Falcone, Rosa; Di Rocco, Roberta; Righini, Riccardo; Marchetti, Paolo | |
| Association between proton-pump inhibitors (PPI) and metronomic capecitabine (MCAP) as salvage treatment for patients with advanced gastro-intestinal tumoursa. A randomized phase II study | 2015 | Milano, Annalisa; D'Antonio, Chiara; Roberto, Michela; Falcone, Rosa; DI PIETRO, FRANCESCA ROMANA; Durante, Valeria; Romiti, Adriana; Marchetti, P. | |
| Recent advances for the treatment of pancreatic and biliary tract cancer after first-line treatment failure | 2015 | Onesti, CONCETTA ELISA; Romiti, Adriana; Roberto, Michela; Falcone, Rosa; Marchetti, Paolo | |
| A metronomic schedule as salvage chemotherapy for upper gastrointestinal tract cancer | 2015 | Roberto, Michela; Romiti, Adriana; Onesti, CONCETTA ELISA; D'Antonio, Chiara; Milano, Annalisa; Falcone, Rosa; Barucca, Viola; Palombi, Lucia; Righini, Riccardo; Marchetti, Paolo | |
| A rare case of palatin tonsillar metastasis from small cell lung cancer | 2016 | D'Antonio, Chiara; Lombardini, Alberto; Onesti, CONCETTA ELISA; Falcone, Rosa; Romiti, Adriana; Lombardi, Marianna; Lauro, Salvatore; Marchetti, Paolo | |
| F295-fluorouracil degradation rate (5-FU-DR) could predict toxicity in breast cancer patients treated with capecitabine | 2016 | Onesti, C. E.; Botticelli, A.; Mazzuca, F.; Angelini, S.; Petremolo, A.; Falcone, R.; Roberto, M.; Occhipinti, M.; Romiti, A.; Lionetto, L.; Simmaco, M.; Marchetti, P. | |
| 5-Fluorouracil degradation rate could predict toxicity in stages II-III colorectal cancer patients undergoing adjuvant FOLFOX | 2016 | Onesti, CONCETTA ELISA; Botticelli, Andrea; LA TORRE, Marco; Borro, Marina; Gentile, Giovanna; Romiti, Adriana; Lionetto, Luana; Petremolo, Antonella; Occhipinti, Mario; Roberto, Michela; Falcone, Rosa; Simmaco, Maurizio; Marchetti, Paolo; Mazzuca, Federica | |
| High-doses of proton pump inhibitors in refractory gastro-intestinal cancer: A case series and the state of art | 2016 | Falcone, Rosa; Roberto, Michela; D'Antonio, Chiara; Romiti, Adriana; Milano, Annalisa; Onesti, CONCETTA ELISA; Marchetti, Paolo; Fais, Stefano | |
| Association Between Proton Pump Inhibitors and Metronomic Capecitabine as Salvage Treatment for Patients With Advanced Gastrointestinal Tumors: A Randomized Phase II Trial | 2016 | Marchetti, Paolo; Milano, Annalisa; D'Antonio, Chiara; Romiti, Adriana; Falcone, Rosa; Roberto, Michela; Fais, Stefano | |
| Evolving treatments for advanced gastric cancer: appraisal of the survival trend | 2016 | Roberto, Michela; Romiti, Adriana; Onesti, CONCETTA ELISA; Zullo, Angelo; Falcone, Rosa; Marchetti, Paolo | |
| The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer | 2016 | Romiti, Adriana; Roberto, Michela; D'Antonio, Chiara; Onesti, CONCETTA ELISA; Barucca, Viola; Milano, Annalisa; Gentile, Giovanna; Lionetto, Luana; Medda, Emanuela; Mazzuca, Federica; Botticelli, Andrea; Falcone, Rosa; Simmaco, Maurizio; Marchetti, Paolo | |
| Exploring the Prognostic Role of Microsatellite Instability in Patients With Stage II Colorectal Cancer: A Systematic Review and Meta-Analysis | 2016 | Romiti, Adriana; Rulli, Eliana; Pilozzi, Emanuela; Gerardi, Chiara; Roberto, Michela; Legramandi, Lorenzo; Falcone, Rosa; Pacchetti, Ilaria; Marchetti, Paolo; Floriani, Irene | |
| Evaluation of 5-fluorouracil degradation rate and pharmacogenetic profiling to predict toxicity following adjuvant capecitabine | 2017 | Roberto, Michela; Romiti, Adriana; Botticelli, Andrea; Mazzuca, Federica; Lionetto, Luana; Gentile, Giovanna; Paris, Ida; Falcone, Rosa; Bassanelli, Maria; DI PIETRO, FRANCESCA ROMANA; Onesti, CONCETTA ELISA; Anselmi, Elisabetta; Macrini, Serena; Simmaco, Maurizio; Marchetti, Paolo | |
| Current achievements and future perspectives of metronomic chemotherapy | 2017 | Romiti, Adriana; Falcone, Rosa; Roberto, Michela; Marchetti, Paolo | |
| The role of stereotactic body radiation therapy in oligometastatic colorectal cancer | 2017 | Roberto, Michela; Falcone, Rosa; Mazzuca, Federica; Archibugi, Livia; Castaldi, Nadia; Botticelli, Andrea; Osti, Mattia Falchetto; Marchetti, Paolo | |
| Tackling pancreatic cancer with metronomic chemotherapy | 2017 | Romiti, Adriana; Falcone, Rosa; Roberto, Michela; Marchetti, Paolo |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile